Jochen Harbott

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Anja Möricke, Alfred Reiter, Martin Zimmermann et al. · Blood · 2008 · 610 citations · Full text

Medicine, Oncology, Pediatrics +14

Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

Martin Schrappe, Alfred Reiter, Wolfgang Ludwig et al. · PubMed · 2000 · 609 citations

Medicine, Oncology, Pediatrics +17

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

Anja Möricke, M Zimmermann, Alfred Reiter et al. · Leukemia · 2009 · 521 citations

Medicine, Hematology, Oncology +9

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study

Brian V. Balgobind, Susana C. Raimondi, Jochen Harbott et al. · Blood · 2009 · 447 citations · Full text

Medicine, Hematology, Oncology +14

Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

Charlotte M. Niemeyer, Maurizio Aricò, Giuseppe Basso et al. · PubMed · 1997 · 412 citations

Medicine, Hematology, Pediatrics +14